Trial Profile
Clinical investigation of therapeutic effects of sorafenib on cutaneous angiosarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Haemangiosarcoma
- Focus Therapeutic Use
- 09 May 2015 New trial record